Lupus erythematosus (LE) is termed as an autoimmune chronic condition which involves a spectrum of symptoms. It is a part of the connective tissue diseases. Its cutaneous form is termed as cutaneous lupus erythematosus (CLE). Prevalence of CLE is about 70 cases per 100,000 persons. The least common variety of CLE is lupus profundus (LP)-only 5% of cases. Lupus profundus, although rare, must be kept in the differential diagnoses of ulcerated lesions. It may present as a localized entity or in association with systemic lupus erythematosus (SLE) or it may lead to SLE later in life. Early diagnosis based on histopathology and aggressive treatment is essential to prevent significant physical morbidity and progression to systemic involvement. We report a case of biopsy-proven lupus profundus in a 40-year-old female who presented with high-grade fever and multiple ulcerated lesions. The lesions were appreciated on the left thigh, right gluteus, and left arm. They had an erythematous base and edematous necrotizing centers with purulent discharge. She had a history of oral ulcers, joint pain, photosensitivity, dyspnea, peptic ulcer disease, and signs of depression. Her autoimmune assays were unremarkable. We treated her with antibiotics, oral hydroxychloroquine, and oral corticosteroid. Potassium permanganate wash and methylprednisolone aceponate were applied locally on the lesions. Ulcerated LP is a rare cause of ulcerated/indurated, painful subcutaneous plaques. It may present as a localized entity or in association with SLE or it may lead to SLE later in life.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063387PMC
http://dx.doi.org/10.7759/cureus.2697DOI Listing

Publication Analysis

Top Keywords

lupus profundus
16
lupus erythematosus
12
ulcerated lesions
8
localized entity
8
entity association
8
lead sle
8
sle life
8
lupus
7
profundus case
4
case report
4

Similar Publications

Tumor necrosis factor-alpha (TNF-α) inhibitors are commonly used for management of various autoimmune disorders but can rarely cause isolated cutaneous lupus. This report presents two cases of cutaneous lupus erythematosus (LE) in women aged 38 and 61 after adalimumab treatment for psoriasis highlighting the importance of recognizing these paradoxical reactions for timely management.

View Article and Find Full Text PDF

Lupus mastitis is a presentation of lupus panniculitis that involves subcutaneous fat in patients with systemic lupus erythematosus (SLE). Moreover, lupus mastitis is a rare condition that typically presents as a palpable breast mass. Here, we report the case of a 29-year-old woman with a prior diagnosis of SLE who presented with palpable lumps in both breasts.

View Article and Find Full Text PDF
Article Synopsis
  • Lupus panniculitis is a chronic form of cutaneous lupus that causes painful, firm nodules on areas like the legs, face, and trunk, potentially leading to scarring or loss of fat in those areas.
  • Patients suffering from lipoatrophy due to lupus panniculitis may experience distress, and there is varying information on treating it with fat transfer or fillers.
  • A case study highlights a 37-year-old woman who successfully restored volume in her right cheek using injectable hyaluronic acid filler after experiencing lipoatrophy following a period of stable disease.
View Article and Find Full Text PDF

Herpes zoster (HZ) is a cutaneous viral disease that typically presents with a dermatomal vesicular eruption. Immunosuppressed patients are more likely to have atypical HZ involving chronic ulceration and disseminated distribution, making diagnosis a challenge. The current report describes a unique case of HZ in a woman with systemic lupus on immunosuppressive therapy manifesting as persistent lower extremity ulceration with diffuse dermal and endothelial infection and secondary panniculitis without epidermal involvement.

View Article and Find Full Text PDF

Epidemiology of Isolated Cutaneous Lupus Erythematosus in the Multiethnic Population of Reunion Island: A Retrospective Multicenter Study.

J Rheumatol

January 2025

L. Raffray, MD, PhD, Internal Medicine and Dermatology Unit, and UMR PIMIT "Processus Infectieux en Milieu Insulaire Tropical" CNRS 9192, INSERM 1187, IRD 249, Reunion Island University, Saint Denis, Reunion Island, France.

Article Synopsis
  • * A total of 268 CLE cases were recorded, with a standardized prevalence of 43/100,000 and an estimated incidence of 5.7/100,000 person-years, showing higher rates compared to lighter-skinned populations.
  • * Findings indicate that darker-skinned patients are more likely to experience severe forms of CLE and that certain clinical features may indicate a higher risk of progression to systemic lupus erythematosus (SLE), underscoring the need for tailored patient follow-up.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!